Welcome to our dedicated page for Sunopta SEC filings (Ticker: STKL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
SunOpta Inc. (STKL, SOY) is a Canada-incorporated manufacturer of plant-based beverages, broths and better-for-you snacks that files reports with the U.S. Securities and Exchange Commission. As a cross-listed issuer on Nasdaq and the Toronto Stock Exchange, SunOpta uses SEC filings to provide detailed information on its financial condition, results of operations and material events.
Among the key documents available for SunOpta are annual reports on Form 10‑K and quarterly reports on Form 10‑Q, which present revenue from continuing operations, earnings from continuing operations, adjusted earnings, adjusted EBITDA and discussions of volume growth across beverages, broths and fruit snacks. These filings also describe factors affecting gross margins, capital allocation priorities, leverage targets, tariff impacts and the company’s approach to pass-through pricing with customers.
Current reports on Form 8‑K are particularly relevant for tracking SunOpta’s material announcements. For example, the company has filed 8‑Ks to furnish press releases reporting financial results for specific quarters, under Item 2.02 Results of Operations and Financial Condition. These filings link directly to earnings releases that discuss recent performance, updates to revenue and adjusted EBITDA outlooks, and commentary on operational initiatives.
On this page, investors can access SunOpta’s SEC filings as they are made available through EDGAR, along with AI-powered summaries designed to highlight the most important points in lengthy documents. The filings list also provides a path to insider transaction reports on Form 4, as well as proxy and other governance-related filings, helping users analyze SunOpta’s regulatory disclosures, compensation decisions and ownership changes alongside its reported financial results.
SunOpta Inc. director Hollis Richard Dean acquired 3,248 common shares of SunOpta on February 9, 2026, at a reported price of $6.39 per share. The shares were issued in lieu of cash for his service on the board of directors.
Following this stock award, Dean directly holds 586,665 SunOpta common shares.
SunOpta Inc. director Rebecca Fisher reported receiving 1,760 common shares of SunOpta on February 9, 2026. The shares were issued at $6.39 per share in lieu of cash compensation for her service on the board of directors.
After this equity award, Fisher directly beneficially owns 141,672 common shares of SunOpta. This transaction is reported as an acquisition under a grant, award, or other form of share issuance rather than an open-market purchase.
SunOpta Inc. director Albert D. Bolles reported receiving 1,662 common shares on February 9, 2026 at $6.39 per share. The filing shows this was a grant issued in lieu of cash for his service on the board of directors, rather than an open-market purchase.
After this award, Bolles directly beneficially owns 231,646 SunOpta common shares. The transaction is classified as a grant, award, or other acquisition under insider reporting rules, reflecting the company’s practice of compensating directors partly with equity instead of cash.
SunOpta Inc. reported that its Chief Human Resources Officer, Danielle Marie Duzan, acquired 22,251 Restricted Stock Units on February 9, 2026. Each unit represents a contingent right to receive one share of STKL common stock.
The RSUs vest in three equal annual installments beginning on April 11, 2026, conditioned on her continued employment through each vesting date. The filing states that these Restricted Stock Units do not have an expiration date and are held as direct beneficial ownership.
SunOpta Inc. executive Jennifer Ann Caro, SVP, Sales, received an equity award of 29,854 restricted stock units (RSUs) on February 9, 2026. Each RSU represents a right to receive one share of STKL common stock, with no expiration date.
The RSUs vest in three equal annual installments beginning on April 11, 2026, contingent on her continued employment through each vesting date. After this grant, she beneficially owns 29,854 derivative securities directly.
SunOpta Inc. major holder Oaktree has updated its Schedule 13D to report beneficial ownership of 24,376,032 common shares, representing 19.99% of the class, based on 118,216,917 shares outstanding as of October 31, 2025. This stake includes common shares directly held and common shares issuable upon exchange of Series B-1 Preferred Stock held by Oaktree funds, subject to stated exchange caps.
The filing notes that Brookfield Corporation and Partners Trust now report zero beneficial ownership and are no longer over 5% holders. Oaktree funds have entered voting and support agreements to vote all of their SunOpta shares, and consent to the exchange of their Series B-1 Preferred Stock, in favor of an arrangement under which an affiliate of Pegasus BidCo B.V. will acquire all outstanding SunOpta common shares. The amendment also discloses that an Oaktree affiliate settled an SEC investigation into beneficial ownership reporting with a $375,000 penalty and a cease-and-desist order.
SunOpta Inc. has agreed to be acquired by Pegasus BidCo B.V., an affiliate of Refresco, in an all-cash deal at $6.50 per common share via a court-approved plan of arrangement under Canadian law. Closing is targeted for the second quarter of 2026, subject to a two‑thirds shareholder vote, court approval and antitrust clearances.
Oaktree-managed funds and company insiders have signed voting agreements covering about 19.5% of votes. The agreement includes a $41,450,000 termination fee payable by SunOpta in specified circumstances. After completion, SunOpta will be privately held and its shares will be delisted from Nasdaq and the TSX. The board also amended its severance plan, removing a prior payout cap in connection with change‑of‑control benefits, and expects the transaction to constitute a change in control under that plan.
SunOpta Inc. filed a current report to note that it has updated its previously issued outlook for fiscal 2025. On January 12, 2026, the company issued a press release describing revised expectations for its 2025 revenue and Adjusted EBITDA. That press release is furnished as Exhibit 99.1 and is not treated as filed for liability purposes under the Exchange Act.
SunOpta CEO and director Brian W. Kocher reported equity-related transactions on January 2, 2026 involving restricted stock units (RSUs) and common shares of STKL.
Two RSU tranches covering 48,134 and 24,666 units were converted into an equal number of common shares at an exercise price of $0 per share. To cover income tax withholding tied to these vestings, the company withheld and disposed of 17,281 and 7,595 common shares at $3.71 per share, as noted in the footnotes.
After these transactions, Kocher beneficially owned 145,716 common shares directly and 84,000 common shares indirectly through the Brian W Kocher Revocable Trust, as well as 48,135 and 24,667 RSUs that remain outstanding.
SunOpta Inc. executive, the SVP of R&D and FSQ, reported equity award activity involving company common shares. On 12/16/2025, 10,000 common shares were acquired upon the vesting and settlement of previously granted restricted stock units, reflected with transaction code "M". On the same date, 4,560 common shares were withheld and disposed of at a price of $3.84 per share to cover income tax withholding obligations, shown with transaction code "F".
After these transactions, the reporting person beneficially owned 51,022 SunOpta common shares directly. The reported restricted stock unit award covered in this filing vested in three equal annual installments beginning on December 16, 2023, and does not have an expiration date.